Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Arachidonic Acid and Genistein

supplement:

Arachidonic Acid

supplement:

Genistein

Research Papers that Mention the Interaction

The protein tyrosine kinase inhibitor, 0.5 mM genistein , inhibited arachidonic acid release in basic fibroblast growth factor-stimulated acini, whereas 100 microM vanadate, a protein tyrosine phosphatase inhibitor, enhanced arachidonic acid release.
Cellular signalling  •  1996  |  View Paper
The effect of arachidonic acid on tyrosine kinase activity was inhibited by genistein and was enhanced by sodium vanadate.
Blood  •  1995  |  View Paper
Further, the growth stimulatory effects of both exogenous PGs and endogenous PGs derived from precursor arachidonic acid were attenuated by genistein.
International journal of cancer  •  2009  |  View Paper
Genistein combined with AA reversed the effects of AA alone on the expression of COX-2 and NFkappaB. All three fatty acids increased the expression of PPARgamma in the cells only when combined with genistein.
Our results support the premise that DHA and genistein exert complementary actions whilst genistein is antagonistic to AA for controlling PGE(2) production as well as invasiveness of MDA-MB-231 cells in culture by modulating the level of NFkappaB expression.
The n-3 PUFA and genistein alone lowered PGE(2) concentration, and genistein in combination with AA reversed the high level of this prostanoid in cell cultures enriched with AA.
Carcinogenesis  •  2007  |  View Paper
We demonstrated that genistein directly inhibited cycloxygenase-2 (COX-2) activity, an inducible enzyme that converts arachidonic acid to prostaglandins, similar to the action of celecoxib, a selective COX-2 inhibitor.
Cancer letters  •  2004  |  View Paper
We initially observed that this arachidonic acid-mediated adhesion was inhibited by the tyrosine kinase inhibitor genistein.
The Journal of Biological Chemistry  •  2000  |  View Paper
Moreover, the tyrosine kinase inhibitor genistein was able to significantly inhibit arachidonic acid mobilisation.
Biochemical pharmacology  •  1999  |  View Paper
The protein tyrosine-kinase inhibitor genistein causes a little decrease in the type IIB vWF-induced release of arachidonic acid.
Thrombosis and haemostasis  •  1996  |  View Paper
Both E2 and genistein could reverse levels of AA , EPA and ergocalciferol to sham levels.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology  •  2010  |  View Paper
Isoflavone aglycones, such as daidzein, genistein , biochanin A, and formononetin significantly suppressed arachidonic acid release (50 microM).
Molecular nutrition & food research  •  2005  |  View Paper
Show More